Highlight Therapeutics is a startup based in Spain, most recent round Series-c-plus, 2 tracked investors.
Highlight Therapeutics is a company founded in 2018 headquartered in Spain. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Highlight Therapeutics is a clinical-stage biotechnology company developing a new class of RNA-based drugs (DRP) for cancer treatment. Their lead product, BO-112, targets solid tumors like melanoma, lung, and liver cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.